Strober , Bruce, Akihiko Asahina, Ulrich Mrowietz, Mark Lebwohl, Peter Foley, Richard Langley, Jonathan Barker, Christopher Cioffi, Nancy Cross, Maggie Wang, and Carle Paul. “Bimekizumab Response Maintenance through Two Years of Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Responded After 16 Weeks: Interim Results from the BE BRIGHT Open-Label Extension Trial”. SKIN The Journal of Cutaneous Medicine 5, no. 6 (November 5, 2021): s52. Accessed August 16, 2022. https://jofskin.org/index.php/skin/article/view/1403.